395 related articles for article (PubMed ID: 12027916)
41. Psychometric evaluation of the Serbian version of the Quality of Life in Epilepsy Inventory-31 (QOLIE-31).
Martinović Z; Milovanović M; Tosković O; Jovanović M; Buder N; Simonović P; Dokić R
Seizure; 2010 Oct; 19(8):517-24. PubMed ID: 20705490
[TBL] [Abstract][Full Text] [Related]
42. Conversion from carbamazepine or oxcarbazepine to topiramate in adolescents and adults with epilepsy.
Kowalik A; Rimpau W; Adam H; Kühn F; van Oene J; Schreiner A; Bogdanow M; Schauble B;
Acta Neurol Scand; 2008 Mar; 117(3):159-66. PubMed ID: 18218062
[TBL] [Abstract][Full Text] [Related]
43. Quality of life after switching to generic levetiracetam - A prospective comparative study.
Olsson P; Reimers A; Källén K
Epilepsy Behav; 2019 Jul; 96():169-174. PubMed ID: 31150996
[TBL] [Abstract][Full Text] [Related]
44. Evaluating health-related quality of life outcomes in clinical trials of antiepileptic drug therapy.
Kline Leidy N; Rentz AM; Grace EM
Epilepsia; 1998 Sep; 39(9):965-77. PubMed ID: 9738676
[TBL] [Abstract][Full Text] [Related]
45. Sensitivity and responsiveness of the EQ-5D-3L in patients with uncontrolled focal seizures: an analysis of Phase III trials of adjunctive brivaracetam.
Mukuria C; Young T; Keetharuth A; Borghs S; Brazier J
Qual Life Res; 2017 Mar; 26(3):749-759. PubMed ID: 28004320
[TBL] [Abstract][Full Text] [Related]
46. Quality of life and its association with comorbidities and adverse events from antiepileptic medications: Online survey of patients with epilepsy in Australia.
Welton JM; Walker C; Riney K; Ng A; Todd L; D'Souza WJ
Epilepsy Behav; 2020 Mar; 104(Pt A):106856. PubMed ID: 31954268
[TBL] [Abstract][Full Text] [Related]
47. Determinants of quality of life in patients with refractory focal epilepsy who were not eligible for surgery or who rejected surgery.
Elsharkawy AE; Thorbecke R; Ebner A; May TW
Epilepsy Behav; 2012 Jun; 24(2):249-55. PubMed ID: 22534356
[TBL] [Abstract][Full Text] [Related]
48. PatientsLikeMe® Online Epilepsy Community: Patient characteristics and predictors of poor health-related quality of life.
de la Loge C; Dimova S; Mueller K; Phillips G; Durgin TL; Wicks P; Borghs S
Epilepsy Behav; 2016 Oct; 63():20-28. PubMed ID: 27544877
[TBL] [Abstract][Full Text] [Related]
49. Health-related quality of life in Russian adults with epilepsy: the effect of socio-demographic and clinical factors.
Melikyan E; Guekht A; Milchakova L; Lebedeva A; Bondareva I; Gusev E
Epilepsy Behav; 2012 Dec; 25(4):670-5. PubMed ID: 23158775
[TBL] [Abstract][Full Text] [Related]
50. Treatment factors affecting longitudinal quality of life in new onset pediatric epilepsy.
Modi AC; Ingerski LM; Rausch JR; Glauser TA
J Pediatr Psychol; 2011 May; 36(4):466-75. PubMed ID: 21278379
[TBL] [Abstract][Full Text] [Related]
51. Comparison between the QOLIE-31 and derived QOLIE-10 in a clinical trial of levetiracetam.
Cramer JA; Arrigo C; Van Hammée G; Bromfield EB
Epilepsy Res; 2000 Aug; 41(1):29-38. PubMed ID: 10924866
[TBL] [Abstract][Full Text] [Related]
52. Long-term outcome and determinants of quality of life after temporal lobe epilepsy surgery in adults.
Elsharkawy AE; May T; Thorbecke R; Koch-Stoecker S; Villagran A; Urak L; Pfäfflin M; Pannek H; Pietilä TA; Ebner A
Epilepsy Res; 2009 Oct; 86(2-3):191-9. PubMed ID: 19632095
[TBL] [Abstract][Full Text] [Related]
53. Cognitive consequences of early versus late antiepileptic drug withdrawal after pediatric epilepsy surgery, the TimeToStop (TTS) trial: study protocol for a randomized controlled trial.
Boshuisen K; Lamberink HJ; van Schooneveld MM; Cross JH; Arzimanoglou A; van der Tweel I; Geleijns K; Uiterwaal CS; Braun KP
Trials; 2015 Oct; 16():482. PubMed ID: 26503021
[TBL] [Abstract][Full Text] [Related]
54. Lamotrigine versus carbamazepine monotherapy for epilepsy.
Gamble CL; Williamson PR; Marson AG
Cochrane Database Syst Rev; 2006 Jan; (1):CD001031. PubMed ID: 16437428
[TBL] [Abstract][Full Text] [Related]
55. Improved quality of life in patients with partial seizures after conversion to oxcarbazepine monotherapy.
Sachdeo RC; Gates JR; Bazil CW; Barkley GL; Tatum W; D'Souza J; McCague K
Epilepsy Behav; 2006 Nov; 9(3):457-63. PubMed ID: 16934534
[TBL] [Abstract][Full Text] [Related]
56. Health-related quality of life after epilepsy surgery: a Swedish multicenter study.
Malmgren K; Sullivan M; Ekstedt G; Kullberg G; Kumlien E
Epilepsia; 1997 Jul; 38(7):830-8. PubMed ID: 9579911
[TBL] [Abstract][Full Text] [Related]
57. Factors affecting quality of life in adults with epilepsy in Taiwan: A cross-sectional, correlational study.
Chen HF; Tsai YF; Hsi MS; Chen JC
Epilepsy Behav; 2016 May; 58():26-32. PubMed ID: 27002941
[TBL] [Abstract][Full Text] [Related]
58. Correlation between adherence to antiepileptic drugs and quality of life in patients with epilepsy: A longitudinal study.
Lin CY; Chen H; Pakpour AH
Epilepsy Behav; 2016 Oct; 63():103-108. PubMed ID: 27588360
[TBL] [Abstract][Full Text] [Related]
59. Systematic testing of medical intractability for carbamazepine, phenytoin, and phenobarbital or primidone in monotherapy for patients considered for epilepsy surgery.
Hermanns G; Noachtar S; Tuxhorn I; Holthausen H; Ebner A; Wolf P
Epilepsia; 1996 Jul; 37(7):675-9. PubMed ID: 8681900
[TBL] [Abstract][Full Text] [Related]
60. Quality of life in adults enrolled in an open-label study of cannabidiol (CBD) for treatment-resistant epilepsy.
Gaston TE; Szaflarski M; Hansen B; Bebin EM; Szaflarski JP;
Epilepsy Behav; 2019 Jun; 95():10-17. PubMed ID: 31003195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]